Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2004
12/14/2004CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/11/2004CA2431560A1 Derivatives of streptogramins, their preparation and compositions containing them
12/09/2004WO2004106522A1 Gene encoding a ribosome-inactivating protein, known as recombinant musarmin 4, expression in bacterial system, method of obtaining same and applications thereof
12/09/2004WO2004106411A2 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004WO2004106376A1 Compositions comprising large and small binding fragments of antibodies against the same toxin
12/09/2004WO2004106364A1 Stabilizing peptides and their use in the preparation of stabilized hiv inhibitors
12/09/2004WO2004106356A1 Functionalized nucleotide derivatives
12/09/2004WO2004106350A1 Nucleoside analogs as viral polymerase inhibitors
12/09/2004WO2004106345A2 Heteroaryl-ethanolamine derivatives as antiviral agents
12/09/2004WO2004106329A2 Novel antiinfective compounds and their pharmaceutical compositions
12/09/2004WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004WO2004105824A1 A bioabsorbable delivery system
12/09/2004WO2004105792A1 Composition against parvovirus infection
12/09/2004WO2004105779A2 Green tea and oplyphenol inhibitors of bacterial proteases
12/09/2004WO2004105745A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant
12/09/2004WO2004105492A1 Aqueous compositions for disinfection and/or sterilization
12/09/2004WO2004092209A3 S. pneumoniae antigens
12/09/2004WO2004060262A3 Modulators of notch signalling for use in immunotherpapy
12/09/2004WO2003090687A8 Using heat shock proteins to increase immune response
12/09/2004WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies
12/09/2004US20040249175 Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol
12/09/2004US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004US20040249143 Hagfish cathelin-associated antimicrobial peptides and genes
12/09/2004US20040249133 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
12/09/2004US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004US20040249125 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
12/09/2004US20040249124 Viral protein for use in generation of immunogllobulins to prevent lymphadenopathy associated viral infections; immunotherapy; viricides
12/09/2004US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004US20040248967 Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
12/09/2004US20040248944 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
12/09/2004US20040248941 such as 4-[2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazol-1-yl]-1,3-dioxolan-2-one, used as prodrugs to lansoprazole; proton pump inhibitors; antiulcer agents
12/09/2004US20040248928 Cardiovascular system protection; ischemic attack, reperfusion, cardiac surgery
12/09/2004US20040248917 Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
12/09/2004US20040248903 Pyrazolo-pyridine derivatives as antiherpes agents
12/09/2004US20040248885 Use of thiazole derivatives for preparing a medicine for protecting mitochondria
12/09/2004US20040248875 Such as 7-[-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-[3-amino-4-(3-aminopropyl)-2-methyl-1-pyrazolio]methyl-3-cephem-4-carboxylate; antimicrobial agents; synthesis
12/09/2004US20040248874 Anti-microbial composition comprising a metal ion chelating agent
12/09/2004US20040248844 Method for the treatment or prevention of Flavivirus infections using nucleoside analogues
12/09/2004US20040248839 RNAi targeting of viruses
12/09/2004US20040248835 Administering by inhalation, injection or orally; Rna interference in vitro; genetic engineering
12/09/2004US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents
12/09/2004US20040248789 peptides/fusion inhibitors;
12/09/2004US20040248768 Nutritional composition preventing bacterial overgrowth
12/09/2004US20040248767 Modulating serum amyloid a interaction with tanis and agents useful for same
12/09/2004US20040248765 Tumour targeting prodrugs activated by metallo matrixproteinases
12/09/2004US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004US20040248296 HIV therapeutic
12/09/2004US20040248251 Receptors and membrane associated proteins
12/09/2004US20040248241 Compositions and methods for eliciting an immune response to Gram-negative bacterial infections
12/09/2004US20040248124 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
12/09/2004US20040247711 Process for the production of allicin
12/09/2004US20040247650 Zinc, copper, selenium or iron bound to or absorbed into the material matrix; wound healing agents; neovascularization; antiulcer agents; burn treatments before skin transplants; acute infections
12/09/2004US20040247616 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
12/09/2004US20040247615 A nucleic acid comprising a nucleotide sequence encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region; adenovector or DNA plasmid vaccine; cultured cells expressing the nucleic acid; vaccination
12/09/2004US20040247560 Improved palatability, especially masking the bitter taste of quinolone antibiotics; particle size of less than 50 mu m. delays the formation of a sediment and means that the sediment is very easy to reagitate.
12/09/2004DE10321905A1 Verwendung von Kombinationen aus Hemmern der reversen Transkriptase und Hemmern der viruscodierten DNA-Polymerase Using combinations of reverse transcriptase inhibitors and inhibitors of the virus-coded DNA polymerase
12/09/2004CA2527722A1 Biodegradable poly(beta-amino esters) and uses thereof
12/08/2004EP1484404A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
12/08/2004EP1484402A2 Antibody for use in therapy
12/08/2004EP1484391A1 Vaccine against mumps
12/08/2004EP1484339A2 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
12/08/2004EP1484328A1 Derivatives of quinolyl-propyl-piperidine and their use as antimicrobial agents
12/08/2004EP1484327A1 Nitrogenous heterocyclic compound and medicine thereof
12/08/2004EP1484066A1 Remedy for infections
12/08/2004EP1484064A1 Therapeutical composition containing dentritic cells and use thereof
12/08/2004EP1484062A1 Crystalline azithromycin, process for manufacture and pharmaceutical compositions thereof
12/08/2004EP1484059A2 Antiviral composition comprising phenylacetic acid derivatives
12/08/2004EP1484058A2 Pharmaceutical composition for inhibiting altering gene expression and for inducing differentiation in non-malignant cells
12/08/2004EP1484054A1 Drug delivery system for the subconjunctival administration of fine grains
12/08/2004EP1483575A2 Methods for isolating ligands e.g. t cell epitopes
12/08/2004EP1483385A2 Compositions and methods for generating an immune response
12/08/2004EP1483374A2 Use of l-alpha-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo
12/08/2004EP1483366A1 Antimicrobial composition
12/08/2004EP1483292A1 Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins
12/08/2004EP1483286A1 A process for the production of ramoplanin-like amide derivatives
12/08/2004EP1483281A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
12/08/2004EP1483260A1 Cdk inhibiting 2-heteroaryl pyrimidine, the production thereof, and use thereof as a medicament
12/08/2004EP1483253A1 An antimicrobial agent
12/08/2004EP1483244A1 Cyclic n-substituted alpha iminocarboxylic acids for selectively inhibiting collagenase
12/08/2004EP1482988A1 METHOD OF RADIO−LABELLING BIOMOLECULES
12/08/2004EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004EP1482974A2 Electroporation methods for introducing bioactive agents into cells
12/08/2004EP1482973A1 Methods of modulating cd200 receptors
12/08/2004EP1482972A2 Treatment of immunological disorders using anti-cd30 antibodies
12/08/2004EP1482971A1 Strategy for retroviral immunotherapy
12/08/2004EP1482962A2 Method of treating trx mediated diseases
12/08/2004EP1482960A2 Methods and products for oral care
12/08/2004EP1482959A1 Compositions and methods for treatment of skin disorders
12/08/2004EP1482955A1 Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
12/08/2004EP1482943A2 Dosing regimen for gemcitabine hcv therapy
12/08/2004EP1482937A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
12/08/2004EP1482936A1 Ophthalmic composition comprising ascomycin
12/08/2004EP1482933A2 Potent, simplified derivatives of immunosuppressive agents
12/08/2004EP1482930A1 Peptide deformylase inhibitors
12/08/2004EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004EP1482911A1 Dispersed solid-containing complex carbohydrate
12/08/2004EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004EP1482811A1 Probiotic delivery system
12/08/2004EP1482795A1 New immunoeffector compounds